FATE
Fate Therapeutics·NASDAQ
--
--(--)
--
--(--)
FATE fundamentals
Fate Therapeutics (FATE) released its earnings on Aug 12, 2025: revenue was 1.91M (YoY -71.84%), beat estimates; EPS was -0.29 (YoY +12.12%), beat estimates.
Revenue / YoY
1.91M
-71.84%
EPS / YoY
-0.29
+12.12%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 12, 2025
Meeting link.EPS
Actual | -0.44 | -0.35 | -0.68 | -0.61 | -0.48 | -0.58 | -0.45 | -0.72 | -0.68 | -0.79 | -0.86 | -0.58 | -0.19 | -0.54 | -0.46 | -0.45 | -0.47 | -0.33 | -0.4 | -0.44 | -0.32 | -0.29 | |||||||||||
Forecast | -0.3891 | -0.27 | -0.3301 | -0.3931 | -0.4346 | -0.5197 | -0.5695 | -0.6661 | -0.7651 | -0.8291 | -0.895 | -0.8624 | -0.6229 | -0.5885 | -0.5599 | -0.5222 | -0.4718 | -0.4635 | -0.4165 | -0.4325 | -0.3833 | -0.3508 | |||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -13.08% | -29.63% | -106.00% | -55.18% | -10.45% | -11.60% | +20.98% | -8.09% | +11.12% | +4.72% | +3.91% | +32.75% | +69.50% | +8.24% | +17.84% | +13.83% | +0.38% | +28.80% | +3.96% | -1.73% | +16.51% | +17.33% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 2.52M | 5.46M | 7.56M | 15.90M | 11.14M | 13.41M | 14.22M | 17.07M | 18.41M | 18.55M | 14.98M | 44.36M | 58.98M | 933.00K | 1.94M | 1.68M | 1.93M | 6.77M | 3.07M | 1.86M | 1.63M | 1.91M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.75M | 13.97M | 7.26M | 5.02M | 6.58M | 6.75M | 8.10M | 11.31M | 9.01M | 12.54M | 15.28M | 17.88M | 34.42M | 5.41M | 1.55M | 1.54M | 1.66M | 1.33M | 1.24M | 1.37M | 1.07M | 864.25K |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +43.56% | -60.87% | +4.07% | +216.90% | +69.42% | +98.58% | +75.64% | +50.91% | +104.34% | +47.95% | -1.96% | +148.07% | +71.35% | -82.76% | +25.23% | +8.97% | +15.94% | +410.53% | +147.45% | +35.44% | +52.81% | +120.65% |
Earnings Call
You can ask Aime
What guidance did Fate Therapeutics's management provide for the next earnings period?What factors drove the changes in Fate Therapeutics's revenue and profit?What were the key takeaways from Fate Therapeutics’s earnings call?What is Fate Therapeutics's gross profit margin?Did Fate Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Fate Therapeutics next quarter?What does Fate Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Fate Therapeutics year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
